(TheNewswire)
LittleGreen Pharma Acquires Danish Cannabis Facility
MONTRÉAL – TheNewswire - June 24, 2021 -- Elixxer Ltd. (TSXV:ELXR) (OTC:ELIXF) (FRA:2LQA) (“ Elixxer ” or the“ Company ”) is pleased to announce that its largest holding (27.4Mshares) of Little Green Pharma Ltd. (“ LGP ”), has acquired a cannabis GACP cultivation and EU-recognisedGMP-licensed cannabis production facility located in Denmark (the“ DenmarkFacility ”), as well as the receipt of firmcommitments to raise A$27.2 million by way of placement toinstitutional and sophisticated investors.
Ferras Zalt, Chairman and Interim CEO of Elixxercommented, “Our decision toinvest in LGP was calculated, and our continued strategy of seekingand investing in companies that are leading this industry, is havingsignificant returns. LGP’s acquisition is an efficient use of itscapital.”
Currently, LGP has a market cap of $141M on the ASX,and Elixxer holds 27.4M or 13.4%. On June 24, 2021, the closing priceof LGP was $0.81 per share on the ASX. LGPShare Price Elixxer’s initial investmentin LGP was $8.2M. For details on Elixxer’s initial investment inLGP, please see the Company’s press releases of October 12, 2017,December 14, 2017, February 16, 2018, May 22, 2019 and August 26,2019.
For a full update from LGP’s AGM update please click: https://investor.littlegreenpharma.com/site/showdownloaddoc.aspx?AnnounceGuid=8375cb79-32bb-4e35-957d-e19fb3f59f69&TE=lenigas@monaco-capital.com
-30-
About Elixxer Ltd. ( www.Elixxer.com )
Elixxer is a Canadian public company listed on the TSXVenture Exchange (TSX-V:ELXR) and the US OTC-QB exchange (OTCQB:ELIXF).
Through its partners, Elixxer presently has significantinterests in Australia, Jamaica, Switzerland, Italy and Canada. TheCompany’s strategy is to seek and invest in emerging leaders.
For further information, pleasecontact:
Ferras Zalt, Chairman and Interim CEO: +44 20 74096680; f erras @elixxer.com
Caution Regarding PressReleases
Neither the TSX Venture Exchange nor its RegulationService Provider (as that term is defined in the policies of the TSX VentureExchange) accepts responsibility for the adequacy or accuracy of this release.
Notice Regarding Forward LookingStatements
This press release may contain forward-lookingstatements with respect to Elixxer and its operations, strategy,investments, financial performance and condition. These statements cangenerally be identified by use of forward-looking words such as“may”, “will”, “expect”, “estimate”, “anticipate”,“intends”, “believe” or “continue” or the negative thereofor similar variations. The actual results and performance of Elixxercould differ materially from those expressed or implied by suchstatements. Such statements are qualified in their entirety by theinherent risks and uncertainties surrounding future expectations. Someimportant factors that could cause actual results to differ materially from expectations include, among otherthings, general economic and market factors, competition, governmentregulation and the factors described under “Risk Factors and RiskManagement” in Elixxer’s most recent Management’s Discussion andAnalysis filed on SEDAR (www.sedar.com). The cautionary statementsqualify all forward-looking statements attributable to Elixxer andpersons acting on its behalf. Unless otherwise stated, allforward-looking statements speak only as of the date of this pressrelease, and Elixxer has no obligation to update such statements,except to the extent required by applicable securities laws.
Copyright (c) 2021 TheNewswire - All rights reserved.